ArticleEBioMedicine2018

Inhibition of HDACs-EphA2 Signaling Axis with WW437 Demonstrates Promising Preclinical Antitumor Activity in Breast Cancer.

Tao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.